{"lastClose": 1.1200000047683716, "len": 479, "date": "2023-02-10", "alpha_1": -0.9128110679043275, "beta_1": 0.19521523154284579, "drawup_1": 0.7325581218050006, "natr_1": 32.58241578066532, "sup_1": -0.4934523411019119, "res_1": 0.003273802839827743, "bullPattern_1": [], "bearPattern_1": ["CLOSINGMARUBOZU", "LONGLINE"], "rsi_1": 64.06249320910902, "adx_1": 48.46038521987634, "drawdown_1": -0.9065934078890032, "stratHoldSharpe_1": -1.8712733549163463, "stratHoldAlpha_1": 249.6995401874467, "stratHoldDrawdown_1": -0.8177312854970592, "alpha_3mo": -0.659272097186751, "beta_3mo": -0.3839168674225777, "drawup_3mo": 0.4117647223819081, "natr_3mo": 32.58241578066532, "sup_3mo": -0.08035717231734663, "res_3mo": 0.008928509657176436, "bullPattern_3mo": [], "bearPattern_3mo": ["CLOSINGMARUBOZU"], "rsi_3mo": 70.74687418963393, "adx_3mo": 85.7890928066651, "drawdown_3mo": -0.4295301889923263, "stratHoldSharpe_3mo": 0.5343225696364104, "stratHoldAlpha_3mo": 251.37402104772582, "stratHoldDrawdown_3mo": -0.39751551553315534, "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Country": "Cayman Islands", "Name": "LumiraDx Limited", "Sector": "Health Care", "Market Cap": 298185583, "alpha%_1": 0.003935032532717622, "beta%_1": 0.061106170667887656, "drawup%_1": 0.691142842292301, "natr%_1": 1.0, "drawdown%_1": 0.004223740399518825, "stratHoldSharpe%_1": 0.003034282501984907, "stratHoldAlpha%_1": 2.480972243806242e-07, "stratHoldDrawdown%_1": 0.004994602263987685, "alpha%_3mo": 0.08796270504649911, "beta%_3mo": 0.009220193452026784, "drawup%_3mo": 0.822838062430359, "natr%_3mo": 1.0, "drawdown%_3mo": 0.0008555966361077084, "stratHoldSharpe%_3mo": 0.4329467969046559, "stratHoldAlpha%_3mo": 0.6248193858866512, "stratHoldDrawdown%_3mo": 0.000594885979185231}